AU2004285928B2 - Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction - Google Patents
Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction Download PDFInfo
- Publication number
- AU2004285928B2 AU2004285928B2 AU2004285928A AU2004285928A AU2004285928B2 AU 2004285928 B2 AU2004285928 B2 AU 2004285928B2 AU 2004285928 A AU2004285928 A AU 2004285928A AU 2004285928 A AU2004285928 A AU 2004285928A AU 2004285928 B2 AU2004285928 B2 AU 2004285928B2
- Authority
- AU
- Australia
- Prior art keywords
- protein
- target protein
- adsorbent
- flow
- hydrophobic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51448603P | 2003-10-24 | 2003-10-24 | |
US60/514,486 | 2003-10-24 | ||
PCT/US2004/035007 WO2005042569A1 (en) | 2003-10-24 | 2004-10-22 | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2004285928A1 AU2004285928A1 (en) | 2005-05-12 |
AU2004285928B2 true AU2004285928B2 (en) | 2012-02-02 |
Family
ID=34549339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2004285928A Active AU2004285928B2 (en) | 2003-10-24 | 2004-10-22 | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
Country Status (8)
Country | Link |
---|---|
US (1) | US7427659B2 (es) |
EP (1) | EP1687328B1 (es) |
AT (1) | ATE462716T1 (es) |
AU (1) | AU2004285928B2 (es) |
CA (1) | CA2542951C (es) |
DE (1) | DE602004026343D1 (es) |
ES (1) | ES2342539T3 (es) |
WO (1) | WO2005042569A1 (es) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1380290A1 (en) | 2002-07-09 | 2004-01-14 | Universitair Medisch Centrum Utrecht | Cross-beta structure pathway and its therapeutic relevance |
DE602004026343D1 (de) * | 2003-10-24 | 2010-05-12 | Amgen Inc | Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen |
HUE049797T2 (hu) | 2005-03-11 | 2020-10-28 | Wyeth Llc | Gyenge megoszlási kromatográfiás eljárás |
US20070015133A1 (en) * | 2005-07-13 | 2007-01-18 | Umc Utrecht Holding B.V. | Method for detecting and/or removing protein and/or peptide comprising a cross-beta structure from an aqueous solution comprising a protein |
US8114832B2 (en) | 2005-07-13 | 2012-02-14 | Crossbeta Biosciences B.V. | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition |
EP2386861A3 (en) | 2005-07-13 | 2012-07-18 | Crossbeta Biosciences B.V. | Cross-ß structure binding compounds |
US7566401B2 (en) * | 2005-10-03 | 2009-07-28 | Kelm Mark A | Process for separating and isolating xanthines, individual polar protic monomers, and polar protic oligomers |
ES2439641T3 (es) | 2005-12-20 | 2014-01-24 | Bristol-Myers Squibb Company | Composiciones y procedimientos de producción de una composición |
AR058568A1 (es) | 2005-12-20 | 2008-02-13 | Bristol Myers Squibb Co | Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo |
US9605035B2 (en) | 2008-01-10 | 2017-03-28 | Research Development Foundation | Vaccines and diagnostics for the ehrlichioses |
US8188242B2 (en) * | 2008-04-08 | 2012-05-29 | Bio-Rad Laboratories, Inc. | Chromatography purification of antibodies |
NZ590257A (en) * | 2008-07-18 | 2012-08-31 | Grifols Therapeutics Inc | Method of preparing alpha-1 proteinase inhibitor |
EP2445924B2 (en) | 2009-06-25 | 2023-12-13 | Amgen Inc. | Capture purification processes for proteins expressed in a non-mammalian system |
RU2012122240A (ru) | 2009-10-30 | 2013-12-10 | Эбботт Лэборетриз | Конструкции sorf и экспрессия нескольких генов |
EP2652491B1 (en) | 2010-12-15 | 2017-11-29 | Baxalta GmbH | Eluate collection using conductivity gradient |
EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
US9783570B2 (en) | 2011-07-01 | 2017-10-10 | Hoffmann-La Roche Inc. | Method for separation of monomeric polypeptides from aggregated polypeptides |
JP6280499B2 (ja) * | 2011-07-08 | 2018-02-14 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Fc融合タンパク質の精製方法 |
KR101454316B1 (ko) * | 2011-08-17 | 2014-10-27 | 한화케미칼 주식회사 | 활성형 TNFR-Fc 융합 단백질을 제조하는 방법 |
SG10201701224UA (en) | 2012-03-12 | 2017-04-27 | Merck Patent Gmbh | Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode |
US9334319B2 (en) | 2012-04-20 | 2016-05-10 | Abbvie Inc. | Low acidic species compositions |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
US9505833B2 (en) | 2012-04-20 | 2016-11-29 | Abbvie Inc. | Human antibodies that bind human TNF-alpha and methods of preparing the same |
WO2013176754A1 (en) * | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
US9206390B2 (en) | 2012-09-02 | 2015-12-08 | Abbvie, Inc. | Methods to control protein heterogeneity |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
US10023608B1 (en) | 2013-03-13 | 2018-07-17 | Amgen Inc. | Protein purification methods to remove impurities |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
PL2970378T3 (pl) * | 2013-03-15 | 2021-12-06 | Biogen Ma Inc. | Chromatografia oddziaływań hydrofobowych białek w warunkach bez soli |
EP3052640A2 (en) | 2013-10-04 | 2016-08-10 | AbbVie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
KR101891522B1 (ko) | 2013-12-12 | 2018-08-24 | 이엠디 밀리포어 코포레이션 | 아크릴아미드 함유 필터를 사용한 단백질 분리 |
SG11201607341SA (en) * | 2014-03-04 | 2016-10-28 | Merck Patent Gmbh | Robust antibody purification |
TW201628649A (zh) | 2014-10-09 | 2016-08-16 | 再生元醫藥公司 | 減少醫藥調配物中微可見顆粒之方法 |
MX2019000935A (es) | 2016-08-16 | 2019-07-04 | Regeneron Pharma | Metodos para cuantificar anticuerpos individuales de una mezcla. |
CN109923411B (zh) | 2016-10-25 | 2022-05-31 | 里珍纳龙药品有限公司 | 用于色谱数据分析的方法和系统 |
JP7097433B2 (ja) | 2017-08-17 | 2022-07-07 | ジャスト-エヴォテック バイオロジックス、インコーポレイテッド | 宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法 |
TW202005694A (zh) | 2018-07-02 | 2020-02-01 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
US20240083972A1 (en) | 2020-12-22 | 2024-03-14 | Amgen Inc. | Cell culture method |
WO2023215750A2 (en) | 2022-05-02 | 2023-11-09 | Regeneron Pharmaceuticals, Inc. | Methods for reducing lipase activity |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468847A (en) * | 1994-03-10 | 1995-11-21 | Minnesota Mining And Manufacturing Company | Method of isolating and purifying a biomacromolecule |
WO1996033208A1 (en) * | 1995-04-20 | 1996-10-24 | Genentech, Inc. | Antibody purification by low-ph hydrophobic interaction chromatoggraphy |
US6005082A (en) * | 1994-11-14 | 1999-12-21 | Genetics Institute, Inc. | Process for purification of factor VIII |
WO2000059927A1 (en) * | 1999-04-01 | 2000-10-12 | Cantab Pharmaceuticals Research Limited | Purification of biological preparations |
US20030009025A1 (en) * | 1993-09-21 | 2003-01-09 | Smith Leonard A. | Recombinant vaccine against botulinum neurotoxin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0449299A (ja) | 1990-06-14 | 1992-02-18 | Tosoh Corp | 免疫グロブリンフラグメントの精製法 |
US5463029A (en) * | 1992-11-23 | 1995-10-31 | Immunex Corporation | Purification of fusion proteins comprising GM-CSF and IL-3 |
US5429746A (en) | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
JP5025874B2 (ja) * | 2000-03-27 | 2012-09-12 | ジェネティクス インスティテュート,エルエルシー | 高アニオン性タンパク質の精製方法 |
DE602004026343D1 (de) * | 2003-10-24 | 2010-05-12 | Amgen Inc | Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen |
-
2004
- 2004-10-22 DE DE602004026343T patent/DE602004026343D1/de active Active
- 2004-10-22 AT AT04796067T patent/ATE462716T1/de not_active IP Right Cessation
- 2004-10-22 US US10/970,860 patent/US7427659B2/en active Active
- 2004-10-22 WO PCT/US2004/035007 patent/WO2005042569A1/en active Application Filing
- 2004-10-22 EP EP04796067A patent/EP1687328B1/en active Active
- 2004-10-22 CA CA2542951A patent/CA2542951C/en active Active
- 2004-10-22 AU AU2004285928A patent/AU2004285928B2/en active Active
- 2004-10-22 ES ES04796067T patent/ES2342539T3/es active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030009025A1 (en) * | 1993-09-21 | 2003-01-09 | Smith Leonard A. | Recombinant vaccine against botulinum neurotoxin |
US5468847A (en) * | 1994-03-10 | 1995-11-21 | Minnesota Mining And Manufacturing Company | Method of isolating and purifying a biomacromolecule |
US6005082A (en) * | 1994-11-14 | 1999-12-21 | Genetics Institute, Inc. | Process for purification of factor VIII |
WO1996033208A1 (en) * | 1995-04-20 | 1996-10-24 | Genentech, Inc. | Antibody purification by low-ph hydrophobic interaction chromatoggraphy |
WO2000059927A1 (en) * | 1999-04-01 | 2000-10-12 | Cantab Pharmaceuticals Research Limited | Purification of biological preparations |
Non-Patent Citations (2)
Title |
---|
SCHOEL, BERND et al. 'Hydrophobic interaction chromatography for the purification of a mycobacterial heat shock protein of relative molecular mass 60 000.' Journal of Chromatography. 1991, Vol. 587, pages 19-23 * |
SCHOEL, BERND et al. 'Hydrophobic interaction for the purification of cytolytic bacterial toxins.' Journal of Chromatography A. 1994, Vol. 667, pages 131-139 * |
Also Published As
Publication number | Publication date |
---|---|
CA2542951C (en) | 2016-08-30 |
US20050136521A1 (en) | 2005-06-23 |
ATE462716T1 (de) | 2010-04-15 |
ES2342539T3 (es) | 2010-07-08 |
WO2005042569A1 (en) | 2005-05-12 |
CA2542951A1 (en) | 2005-05-12 |
EP1687328A1 (en) | 2006-08-09 |
US7427659B2 (en) | 2008-09-23 |
DE602004026343D1 (de) | 2010-05-12 |
EP1687328B1 (en) | 2010-03-31 |
AU2004285928A1 (en) | 2005-05-12 |
EP1687328A4 (en) | 2006-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2004285928B2 (en) | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction | |
US7122641B2 (en) | Methods for purifying protein | |
US8263750B2 (en) | Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step | |
US11492372B2 (en) | Removal of leaked affinity purification ligand | |
US10589996B2 (en) | In situ restoration of apatite-based chromatography resins | |
US10023608B1 (en) | Protein purification methods to remove impurities | |
EP1805205A1 (en) | Methods for refolding polypeptides | |
US7781395B2 (en) | Process for purifying proteins | |
JP2013234154A (ja) | 精製方法 | |
JP2013184919A (ja) | 精製方法 | |
JP2013199454A (ja) | 精製方法 | |
JP2013227254A (ja) | 精製方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |